The Gap Where MedTech Startups Go to Die? She Funds It. | Fehmida Kapadia, Fay Ventures

<p>Fehmida Kapadia has advised more than 150 medtech startups over two decades. Five went on to raise $50 million or more, and three exited. Along the way she built Amplify MedTech, an 800 person network of founders, clinicians, and academics that now sources most of her deal flow. Fay Ventures is her $1 million seed fund for AI enabled medtech founders stuck between a working prototype and FDA clearance.<br /></p><p>She explains the product market fit question most founders never think to ask, why only 3% of US venture firms will touch medtech at all, and how lived experience turns into the perseverance a decade long device company actually demands.</p>